Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2315.HK)

HKD 13.9

(17.0%)

Gross Profit Summary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s latest annual gross profit in 2023 was 506.03 Million CNY , up 29.17% from previous year.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s latest quarterly gross profit in 2024 Q2 was 155.98 Million CNY , down 0.0% from previous quarter.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. reported a annual gross profit of 391.75 Million CNY in annual gross profit 2022, up 58.32% from previous year.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. reported a annual gross profit of 247.44 Million CNY in annual gross profit 2021, up 48.17% from previous year.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. reported a quarterly gross profit of 155.98 Million CNY for 2024 Q1, up 13.61% from previous quarter.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd. reported a quarterly gross profit of 506.03 Million CNY for 2023 FY, up 29.17% from previous quarter.

Annual Gross Profit Chart of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2023 - 2020)

Historical Annual Gross Profit of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (2023 - 2020)

Year Gross Profit Gross Profit Growth
2023 506.03 Million CNY 29.17%
2022 391.75 Million CNY 58.32%
2021 247.44 Million CNY 48.17%
2020 166.99 Million CNY 0.0%

Peer Gross Profit Comparison of Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Name Gross Profit Gross Profit Difference
Uni-Bio Science Group Limited 392.81 Million HKD -28.821%
CK Life Sciences Int'l., (Holdings) Inc. 947.7 Million HKD 46.604%